Absolute eosinophils count as a marker of mortality in patients with severe sepsis and septic shock in an intensive care unit

Journal of Critical Care

Volumn 27, Issue 4, 2012, Pages 394-399

  Merino, Carlos Adolfo ^a,b   Martínez, Felipe Tomás ^b   Cardemil, Felipe ^c   Rodríguez, José Ramón ^b  

^a Hospital Dr Gustavo Fricke   (Chile)

^b UNIVERSIDAD DE VALPARAÍSO   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

Eosinophils; Mortality; Sepsis

Indexed keywords

HYDROCORTISONE;

ABDOMINAL INFECTION; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BONE INFECTION; BRAIN INFECTION; CARDIOGENIC SHOCK; COHORT ANALYSIS; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE SEVERITY; EOSINOPHIL COUNT; FEMALE; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT INFECTION; SEPSIS; SEPTIC SHOCK; SKIN INFECTION; URINARY TRACT INFECTION;

AGED; BIOLOGICAL MARKERS; EOSINOPHILS; FEMALE; HEALTH STATUS INDICATORS; HUMANS; INTENSIVE CARE UNITS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SEPSIS; SHOCK, SEPTIC;

EID: 84864144756     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2011.10.010     Document Type: Article

References (24)

1. Angus D., Linde-Zwirble W., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29(7):1303-1310.
2. Rivers E., Mcintyre L., Morro D., et al. Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity. CMAJ 2005, 173(9):1054-1065.
3. Heper Y., Akalin H., Mistic R., et al. Evaluation of C-reactive protein, tumor necrosis factor alpha, and interleukin-10 as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Microbiol Infect Dis 2006, 25:481-491.
4. Claeys R., Vinken S., Spapen H., et al. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 2002, 30(4):757-762.
5. Castelli G.P., Pognani C., Meisner M., et al. Procalcitonin and C reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care Med 2004, 8(4):R234-242.
6. Castelli G.P., Pognani C., Cita M., et al. Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis. Minerva Anestesiol 2006, 72(1-2):69-80.
7. Cicarelli D.D., Vieira J.E., Benseñor F.E. Comparison of C-reactive protein and serum amyloid A protein in septic shock patients. Mediator Inflamm 2008, 2008:1-5.
8. Renz H., Herzum I. Inflammatory markers in SIRS, sepsis and septic shock. Curr Med Chem 2008, 15(6):581-587.
9. Gibot S., Kolopp-Sarda M.N., Béné M.C., et al. Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 2004, 141:9-15.
10. Shaaban H., Daniel S., Sison R., et al. Eosinopenia: is it a good marker of sepsis in comparison to procalcitonin and C-reactive protein levels for patients admitted to a critical care unit in an urban hospital?. J Crit Care 2010, 25:570-575.
11. Simon C.E. A manual of clinical diagnosis 1922, Henry Klimpton, London.
12. Bass D.A., Gonwa T.A., Szejda P., et al. Eosinopenia of acute infection: production of eosinopenia by chemotactic factors of acute inflammation. J Clin Invest 1980, 65:1265-1271.
13. Rothenberg M.E. Eosinophilia. N Engl J Med 1998, 338:1592-1600.
14. Venet F., Lepape A., Debard A.L., et al. The Th2 response as monitored by CRTH2 or CCR3 expression is severely decreased during septic shock. Clin Immunol 2004, 113(3):278-284.
15. Gil H., Magy N., Mauny F., et al. Value of eosinopenia in inflammatory disorders: an 'old' marker revisited. Rev Med Interne 2003, 24:431-435.
16. Abidi K., Khoudri I., Belayachi J., et al. Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units. Crit Care 2008, 12(2):R59.
17. Abidi K., Belayachi J., Derras Y., et al. Eosinopenia, an early marker of increased mortality in critically ill medical patients. Intensive Care Med 2011, 37:1136-1142.
18. Members of the American College of Chest Physicians/Society of Crit Care Med Consensus Conference Committee: American College of Chest Physicians/Society of Crit Care Med Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874.
19. Levy M., Fink M., Marshall J., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31(4):1250-1256.
20. Akobeng A.K. Understanding diagnostic tests 3: receiver operating characteristics curves. Acta Paediatr 2007, 26(3):259-262.
21. Altman L., Hill J., Hairfield W., et al. Effects of corticosteroids on eosinophil chemotaxis and adherence. J Clin Invest 1981, 67(1):28-36.
22. Póvoa P., Teixeira-Pinto A.M., Carneiro A.H. The Portuguese Community-Acquired Sepsis Study Group (SACiUCI): C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study. Crit Care 2011, 15(4):R169.
23. Coelho L., Póvoa P., Almeida E., et al. Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course. Crit Care 2007, 11(4):R92.
24. Vincent J.L., Donadello K., Schmit X. Biomarkers in the critically ill patient: C-reactive protein. Crit Care Clin 2011, 27(2):241-251.